Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.54
Delayed Data
As of Sep 03
 -0.0101 / -1.84%
Today’s Change
0.49
Today|||52-Week Range
3.72
-22.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues699.0K69.0K1.1M1.7M
 
 
 
 
 
Cost of Goods Sold119.0K------
 
 
Depreciation And Amortization241.0K60.0K70.0K174.0K
 
 
 
 
 
 
Operating ExpensesGross Income339.0K------
 
 
General Expenses16.7M15.1M19.0M24.0M
 
 
 
 
 
Research And Development9.2M6.6M11.3M18.1M
 
 
 
 
 
Total Operating Expenses17.1M15.2M19.1M24.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.4M-15.1M-18.0M-22.4M
 
 
 
 
 
Extraordinary Credit629.0K28.0K570.0K--
 
 
 
 
Extraordinary Charge-20.0K0.000.00-322.0K
 
 
 
Other Expenses-74.0K-54.0K5.5M104.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.8M-15.1M-11.9M-22.6M
 
 
 
 
 
Income Taxes-565.0K-1.4M-1.7M-3.2M
 
 
 
 
 
Preferred Dividend-728.0K-728.0K-9.3M-200.0K
 
 
 
 
 
Discontinued Operations0.00570.0K57.0K19.0K
 
 
 
 
Net Income-15.2M-13.2M-10.2M-19.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.2M8.3M15.2M22.0M
 
 
 
 
 
Shares To Calculate EPS Diluted7.2M8.3M15.2M22.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.24-$1.68-$1.28-$0.89
 
 
 
 
 
EPS Diluted-$2.24-$1.68-$1.28-$0.89